CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Impax Laboratories's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 5, 2020Muco-Adhesive, Controlled Release Formulations Of Levodopa And/Or Esters Of Levodopa And Uses Thereof1
Apr 8, 2020Controlled Release Formulations Of Levodopa And Uses Thereof2
May 8, 2019Rapidly Disintegrating Formulations And Methods Of Use1

Top competitors of Impax Laboratories

Top competitors of Impax Laboratories based on patent oppositions.